← Open Payments lookup

OGOMEGBUNAM OGBONNA: Open Payments

NPI 1134654528 · FT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,518 in 73 payments from 10 companies in 2025. Trend: 2023 $2,499 · 2024 $1,597 · 2025 $1,518

Food & beverage: $1,518
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$470
E.R. Squibb & Sons, L.L.C.13$336
Teva Pharmaceuticals USA, Inc.13$220
Neurocrine BioSciences, Inc.6$175
Janssen Pharmaceuticals, Inc12$158
Vanda Pharmaceuticals Inc.4$79
Axsome Therapeutics, Inc.1$23
Luye Pharma (USA) Ltd.1$21
Otsuka America Pharmaceutical, Inc.1$19
Alkermes, Inc.1$16

Products named: CAPLYTA, COBENFY, AUSTEDO XR, INGREZZA, INVEGA SUSTENNA, FANAPT, UZEDY, Auvelity.

Industry payments across TX — which companies pay providers there.